Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry
Drug discovery chemistry startup Warp Sciences Inc. launched today with $215 million in new funding, six months after co-founder and Chief Executive Kevin Weil left his job running science initiatives at OpenAI Group PBC. Warp is building a chemistry contract research organization in the U.S. to supply biotech and pharmaceutical companies with the molecules their […] The post Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry appeared first on SiliconANGLE.
Why this byte is shareable
Signal quality
observed
Confidence badge and source context included.
Entity anchor
Research
Clear company or model context for distribution.
Export ready
1200 x 630 card
Optimized for X, LinkedIn, and chat previews.
Why it matters
Research is moving the AI stack right now, and this update helps explain what changed for builders.
Suggested launch post
Use this in X threads, community posts, internal team chats, or launch recaps.
Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry Why it matters: Research is moving the AI stack right now, and this update helps explain what changed for builders. Source: Siliconangle https://a2zai.ai/bytes/ex-openai-science-chief-kev...
Permalink: https://a2zai.ai/bytes/ex-openai-science-chief-kevin-weil-launches-warp-sciences-with-215m-for-drug-che-52a6f94b
Social card: https://a2zai.ai/bytes/ex-openai-science-chief-kevin-weil-launches-warp-sciences-with-215m-for-drug-che-52a6f94b/opengraph-image